Clinical Trials
5 trialsNCT05377957 2026-04-15
PROQEM
Leiden University Medical Center
Active not recruiting
NCT06101134 2026-04-09
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations
Bristol-Myers Squibb
Phase 2 Active not recruiting
NCT06046625 2025-04-04
Needs and Preferences of Patients With Head-neck Cutaneous SCC
Maastricht University Medical Center
Active not recruiting
NCT05618912 2024-12-11
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
Indiana University
Phase NA Completed
NCT05115006 2022-06-30
A Study of Adjuvant Melanoma Stakeholder Treatment Preferences
Bristol-Myers Squibb
Completed